SHOUTI
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
SHOUTI
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical Product Research
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.shoutipharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
207 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS Cloudflare Hosting Microsoft DMARC DKIM
Similar Organizations
ArriVent Biopharma
ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Hendrick Resources
Hendrick Resources specializes in the discovery and development of precious and base metals.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Productboard
Productboard is a product management system that helps organizations get the right products to market faster.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Piper Heartland Healthcare Capital
Piper Heartland Healthcare Capital investment in Series B - ShouTi
Deep Track Capital
Deep Track Capital investment in Series B - ShouTi
Surveyor Capital
Surveyor Capital investment in Series B - ShouTi
Woodline Partners
Woodline Partners investment in Series B - ShouTi
TF Capital
TF Capital investment in Series B - ShouTi
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - ShouTi
Casdin Capital
Casdin Capital investment in Series B - ShouTi
Eight Roads Ventures
Eight Roads Ventures investment in Series B - ShouTi
Cormorant Asset Management
Cormorant Asset Management investment in Series B - ShouTi
TCG Crossover
TCG Crossover investment in Series B - ShouTi
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-21 | ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer |
Official Site Inspections
http://www.shoutipharma.com Semrush global rank: 1.97 M Semrush visits lastest month: 10.92 K
Unable to get host informations!!!
More informations about "ShouTi" on Search Engine
ShouTi Secures $100 Million Series B Financing to Accelerate ...
Oct 20, 2021 San Francisco and Shanghai – Oct. 20, 2021 – ShouTi Inc., a clinical-stage biopharmaceutical company creating life-changing medicines for patients using …See details»
Structure Therapeutics - Crunchbase Company Profile & Funding
Also Known As ShouTi Inc. Legal Name Structure Therapeutics, Inc. Stock Symbol NASDAQ:GPCR ; Company Type For Profit; Contact Email [email protected]See details»
Structure Therapeutics Extends Financing, Advances Diabetes …
Aug 1, 2022 San Francisco and Shanghai – August 1, 2022 – Structure Therapeutics Inc. (Structure Therapeutics), formerly known as ShouTi Inc., today announced it closed an …See details»
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary …
Feb 17, 2022 SAN FRANCISCO & SHANGHAI-- ( BUSINESS WIRE )-- ShouTi Inc., a clinical-stage global biopharmaceutical company developing novel oral therapeutics to …See details»
ShouTi Strengthens Board with Appointment of Daniel G. Welch …
Jan 19, 2022 San Francisco and Shanghai – January 20, 2022 – ShouTi Inc., a clinical-stage biopharmaceutical company replacing biologics with world-class small molecule …See details»
ShouTi Strengthens Board With Appointment of …
Jan 20, 2022 The ShouTi team’s deep and proven experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables the company’s …See details»
ShouTi Inc - Company Profile and News - Bloomberg Markets
ShouTi, Inc. operates as a biopharmaceutical company. The Company specializes in the discovery and development of drugs against a type of targets called GPCR. ShouTi …See details»
A new Schrödinger-backed startup emerges from the scientist …
Oct 20, 2021 Raymond Stevens, ShouTi Pharma CEO. October 20, 2021 08:00 AM EDT Updated 10:18 AM. Financing. Startups. A new Schrödinger-backed startup emerges …See details»
ShouTi secures $100M series B funding | Eight Roads
Published. 21.10.2021. ShouTi , a clinical-stage biopharmaceutical company creating life-changing medicines for patients using advanced computational and structure-based …See details»
Receptos founder returns with ShouTi and $100M for oral drugs …
Oct 20, 2021 ShouTi's origins date back to Stevens' work at Receptos, which he co-founded in the late 2000s. Celgene, now owned by Bristol Myers Squibb, bought …See details»
Structure Therapeutics, formerly known as ShoutTi, files for …
Jan 13, 2023 Chinese-American drug developer Structure Therapeutics ( GPCR ), formerly known as ShoutTi, has filed to raise $100M through a US initial public offering.See details»
ShouTi Closes $100 Million Round for Structure-Based Drug …
Publication date: Oct 20, 2021. ShouTi, a San Francisco-Shanghai biopharma, closed a $100 million Series B financing led by BVF Partners that included other China and US …See details»
SEC.gov
Organization and Nature of the Business: Structure Therapeutics Inc. (the “Company”) is a clinical stage global biopharmaceutical company aiming to develop and deliver novel oral …See details»
Structure Therapeutics - Funding, Financials, Valuation & Investors
Investors 21. Funding. Structure Therapeutics has raised a total of. $507M. in funding over 6 rounds. Their latest funding was raised on Sep 29, 2023 from a Post-IPO Equity round. …See details»
Structure Therapeutics - Contacts, Employees, Board Members, …
Structure Therapeutics. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 5. Number of Board Member …See details»
ShouTi Secures $100 Million Series B Financing to Accelerate ...
Oct 20, 2021 SAN FRANCISCO & SHANGHAI-- ( BUSINESS WIRE )-- ShouTi Inc., a clinical-stage biopharmaceutical company creating life-changing medicines for patients …See details»
ShouTi's Board of Directors - Team members and org chart - The …
ShouTi's Board of Directors - Team members and org chart | The Org. Teams. Board of Directors. About. ShouTi's Board of Directors includes Sharon Tetlow and 5 others. …See details»
ShouTi - Org Chart, Teams, Culture & Jobs | The Org
View ShouTi's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Company History – Shout! Factory
Company History 2020 Shout Studios’ new releases included: Misbehaviour (starring Keira Knightley and Gugu Mbatha-Raw) Swift (voiced by Kate Winslet and Willem Dafoe) …See details»
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary …
Feb 17, 2022 San Francisco and Shanghai – February 17, 2022 – ShouTi Inc., a clinical-stage global biopharmaceutical company developing novel oral therapeutics to treat a …See details»